Key result
Pharmacological afterload reduction stabilized 1 of 2 post-STEMI VSR patients for transfer on day 6, whereas 1 patient in cardiogenic shock died on day 5 despite dual-inotropic support.
Why the study?
Post-infarction ventricular septal rupture carries an extremely high death rate, making early identification and prompt medical stabilisation essential at non-surgical institutions without mechanical circulatory support to ensure safe transfer for surgery.
Case Report (n=2)
In non-surgical centers without mechanical circulatory support, early pharmacological afterload reduction in post-STEMI ventricular septal rupture before irreversible multiorgan failure occurs can maintain hemodynamic stability and enable safe transfer for definitive surgical repair.
Background: There is an extremely high death rate linked with post-infarction ventricular septal rupture (VSR), a mechanical consequence of acute myocardial infarction. Early identification and prompt medical stabilisation are essential for VSR in non-surgical institutions without mechanical circulatory support (MCS). This is to ensure a safe transfer between hospitals for final surgery. Case Illustrations: Two individuals with acute VSR after late-presentation anteroseptal ST-elevation myocardial infarction (STEMI) are described in this case series. A male patient, 85 years old, was taken to the hospital in a state of decompensated cardiogenic shock with multiorgan failure after he presented with symptoms 9 days after they began. He was unfit for transfer because his hemodynamic condition remained extremely unstable despite vigorous dual-inotropic support, pharmaceutical optimisation, and constant diuresis. He passed away on the fifth day after a quick decline. In contrast, the baseline hemodynamics and relatively preserved left ventricular function were observed in Patient 2, a 65-year-old male who presented three days after the start of symptoms. His medications for temporary heart failure and new-onset atrial fibrillation were antiplatelets, antiarrhythmics, and pharmacological afterload reduction, all of which helped to stabilise him. Day six saw his secure transport to a tertiary centre for final surgical closure. Conclusions: In non-surgical facilities without MCS, transfer viability depends on preserving end-organ perfusion before irreversible multiorgan failure occurs. Early pharmacological afterload reduction lowers SVR and left-to-right shunting, maintaining hemodynamic stability for transfer, whereas aggressive vasopressor escalation increases afterload, exacerbates shunting, and accelerates clinical collapse.
No takes yet. Share an insight, caveat, or question.
Sahara et al. (2026) conducted a case report in Acute post-infarction ventricular septal rupture after late-presentation anteroseptal ST-elevation myocardial infarction (n=2). Pharmacological afterload reduction and medical stabilization vs. Dual-inotropic support and aggressive vasopressor escalation was evaluated on Hemodynamic stabilization and successful transfer for surgical closure. Pharmacological afterload reduction stabilized 1 of 2 post-STEMI VSR patients for transfer on day 6, whereas 1 patient in cardiogenic shock died on day 5 despite dual-inotropic support.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: